<p>Groups of 10 Balb/c mice were immunized with 2 doses of 2.5 µg CSP, 2 months apart in the indicated adjuvant. Two weeks post second immunization, the mice were bled and the serum was analyzed. <i>A,</i> ELISA end point titers of Balb/c mice, measured against CS/D (left) or NANP repeat peptide (right). <i>B,</i> IgG1 (left) and IgG2a (right) subclasses measured by Luminex and expressed as mean fluorescence intensities (MFI) at 1∶500 serum dilution. <i>C,</i> Percentage of total cytokine<sup>+</sup>CD44<sup>+</sup>CD4<sup>+</sup> T lymphocytes, extracted from vaccinated Balb/c mice and stimulated with CS/D, stained for surface expression of CD3, CD4 and CD44 and intra-cellular expression of IL-2 (left) or IFN-γ (right). Lines are mean with...
<p>Groups of 10 mice received 2 doses, 3 weeks apart of 2.5 μg CSP+Alum, Qβ-CSP+Alum or Qβ-CSP witho...
<p>Groups of BALB/c mice were immunized 3 times i.m. (separated by 4 weeks each) with 2 different do...
<p>For (A) and (B), SEVs (5 μg) and sham (PBS) were injected intramuscularly to mice at weekly inter...
<p>Groups on 10 Balb/c mice were immunized two doses of 2.5 µg CSP, 2 months apart in the indicated ...
<p>Groups on 15 C57Bl/6 mice were immunized with 2 doses of 2.5 µg of CSP, 3 weeks apart, in the ind...
<p>Groups of 15 C57Bl/6 mice were immunized three times, 3 weeks apart, with 2.5 µg of CSP in the in...
<p>Groups of 10 mice received 3 doses, 3 weeks apart of 2.5 μg CSP+SE, Qβ-CSP+SE, CSP+GLA/SE, Qβ-CSP...
<p>(A) OMV-specific IgGs in BALF were detected in mice that were passively immunized with antiserum;...
<p>Mice (n = 5/group) were immunized s.c. twice with alum-based vaccine formulations: Alum+OVA, Alum...
<p>Ten 6-week-old BALB/c mice received 5×10<sup>4</sup> PFU MVTT1, MVTT2 or MVTT3 by intramuscular r...
<p>Groups of three to four mice each were vaccinated at days 0, 14, 28 and 126 (downward pointing op...
<p>Ten days after the last vaccination and 3 months after challenge infection spleens were collected...
<p>Ten days, short-term protection (STP), and twelve weeks, long-term protection (LTP) after final b...
<p>BALB/c mice were immunized with recombinant Em-TSP3 at a dose of 50 µg/mouse plus adjuvant (CpG f...
<p>Groups of 7 mice received three immunizations of 0.1, 1, 2.5, 5 or 10 µg CS/D, adjuvanted with GL...
<p>Groups of 10 mice received 2 doses, 3 weeks apart of 2.5 μg CSP+Alum, Qβ-CSP+Alum or Qβ-CSP witho...
<p>Groups of BALB/c mice were immunized 3 times i.m. (separated by 4 weeks each) with 2 different do...
<p>For (A) and (B), SEVs (5 μg) and sham (PBS) were injected intramuscularly to mice at weekly inter...
<p>Groups on 10 Balb/c mice were immunized two doses of 2.5 µg CSP, 2 months apart in the indicated ...
<p>Groups on 15 C57Bl/6 mice were immunized with 2 doses of 2.5 µg of CSP, 3 weeks apart, in the ind...
<p>Groups of 15 C57Bl/6 mice were immunized three times, 3 weeks apart, with 2.5 µg of CSP in the in...
<p>Groups of 10 mice received 3 doses, 3 weeks apart of 2.5 μg CSP+SE, Qβ-CSP+SE, CSP+GLA/SE, Qβ-CSP...
<p>(A) OMV-specific IgGs in BALF were detected in mice that were passively immunized with antiserum;...
<p>Mice (n = 5/group) were immunized s.c. twice with alum-based vaccine formulations: Alum+OVA, Alum...
<p>Ten 6-week-old BALB/c mice received 5×10<sup>4</sup> PFU MVTT1, MVTT2 or MVTT3 by intramuscular r...
<p>Groups of three to four mice each were vaccinated at days 0, 14, 28 and 126 (downward pointing op...
<p>Ten days after the last vaccination and 3 months after challenge infection spleens were collected...
<p>Ten days, short-term protection (STP), and twelve weeks, long-term protection (LTP) after final b...
<p>BALB/c mice were immunized with recombinant Em-TSP3 at a dose of 50 µg/mouse plus adjuvant (CpG f...
<p>Groups of 7 mice received three immunizations of 0.1, 1, 2.5, 5 or 10 µg CS/D, adjuvanted with GL...
<p>Groups of 10 mice received 2 doses, 3 weeks apart of 2.5 μg CSP+Alum, Qβ-CSP+Alum or Qβ-CSP witho...
<p>Groups of BALB/c mice were immunized 3 times i.m. (separated by 4 weeks each) with 2 different do...
<p>For (A) and (B), SEVs (5 μg) and sham (PBS) were injected intramuscularly to mice at weekly inter...